Your browser doesn't support javascript.
loading
Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms.
Ozga, Michael; Blachly, James; Eisfeld, Ann-Kathrin; Grieselhuber, Nicole; Larkin, Karilyn; Walker, Alison; Bhatnagar, Bhavana; Behbehani, Gregory; Long, Meixiao; Haque, Tamanna; Vasu, Sumithira; Zhao, Weiqiang; Jones, Daniel; Byrd, John C; Mims, Alice S; Saygin, Caner.
Affiliation
  • Ozga M; Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Blachly J; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Eisfeld AK; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Grieselhuber N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Larkin K; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Walker A; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Bhatnagar B; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Behbehani G; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Long M; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Haque T; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Vasu S; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Zhao W; Department of Pathology, The Ohio State University, Columbus, Ohio, USA.
  • Jones D; Department of Pathology, The Ohio State University, Columbus, Ohio, USA.
  • Byrd JC; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Mims AS; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Saygin C; Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
Am J Hematol ; 96(7): E223-E225, 2021 07 01.
Article in En | MEDLINE | ID: mdl-33761147
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid / Neoplasms, Second Primary Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Hematol Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid / Neoplasms, Second Primary Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Hematol Year: 2021 Document type: Article Affiliation country: